Cortez-Pinto H, Chatham J, Chacko V P, Arnold C, Rashid A, Diehl A M
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
JAMA. 1999 Nov 3;282(17):1659-64. doi: 10.1001/jama.282.17.1659.
The mechanisms that drive progression from fatty liver to steatohepatitis and cirrhosis are unknown. In animal models, obese mice with fatty livers are vulnerable to liver adenosine triphosphate (ATP) depletion and necrosis, suggesting that altered hepatic energy homeostasis may be involved.
To determine if patients with fatty liver disease exhibit impaired recovery from hepatic ATP depletion.
Laboratory analysis of liver ATP stores monitored by nuclear magnetic resonance spectroscopy before and after transient hepatic ATP depletion was induced by fructose injection. The study was conducted between July 15 and August 30, 1998.
University hospital.
Eight consecutive adults with biopsy-proven nonalcoholic steatohepatitis and 7 healthy age- and sex-matched controls.
Level of ATP 1 hour after fructose infusion in patients vs controls.
In patients, serum aminotransferase levels were increased (P = .02 vs controls); albumin and bilirubin values were normal and clinical evidence of portal hypertension was absent in both groups. However, 2 patients had moderate fibrosis and 1 had cirrhosis on liver biopsy. Mean serum glucose, cholesterol, and triglyceride levels were similar between groups but patients weighed significantly more than controls (P = .02). Liver ATP levels were similar in the 2 groups before fructose infusion and decreased similarly in both after fructose infusion (P = .01 vs initial ATP levels). However, controls replenished their hepatic ATP stores during the 1-hour follow-up period (P<.02 vs minimum ATP) but patients did not. Hence, patients' hepatic ATP levels were lower than those of controls at the end of the study (P = .04). Body mass index (BMI) correlated inversely with ATP recovery, even in controls (R = -0.768; P = .07). Although BMI was greater in patients than controls (P = .02) and correlated strongly with fatty liver and serum aminotransferase elevations, neither of the latter 2 parameters nor the histologic severity of fibrosis strongly predicted hepatic ATP recovery.
These data suggest that recovery from hepatic ATP depletion becomes progressively less efficient as body mass increases in healthy controls and is severely impaired in patients with obesity-related nonalcoholic steatohepatitis.
从脂肪肝发展为脂肪性肝炎和肝硬化的机制尚不清楚。在动物模型中,患有脂肪肝的肥胖小鼠易发生肝脏三磷酸腺苷(ATP)耗竭和坏死,提示肝脏能量稳态改变可能与之有关。
确定脂肪性肝病患者肝脏ATP耗竭后恢复是否受损。
通过核磁共振波谱法对果糖注射诱导短暂肝脏ATP耗竭前后的肝脏ATP储备进行实验室分析。研究于1998年7月15日至8月30日进行。
大学医院。
8例经活检证实的非酒精性脂肪性肝炎成年患者和7例年龄及性别匹配的健康对照者。
患者与对照者果糖输注1小时后的ATP水平。
患者血清转氨酶水平升高(与对照者相比,P = 0.02);两组白蛋白和胆红素值均正常,且均无门静脉高压的临床证据。然而,2例患者肝脏活检显示有中度纤维化,1例有肝硬化。两组间平均血清葡萄糖、胆固醇和甘油三酯水平相似,但患者体重显著高于对照者(P = 0.02)。果糖输注前两组肝脏ATP水平相似,输注后两组均同样下降(与初始ATP水平相比,P = 0.01)。然而,对照者在1小时的随访期内恢复了肝脏ATP储备(与最低ATP相比,P<0.02),而患者未恢复。因此,研究结束时患者的肝脏ATP水平低于对照者(P = 0.04)。体重指数(BMI)与ATP恢复呈负相关,即使在对照者中也是如此(R = -0.768;P = 0.07)。虽然患者的BMI高于对照者(P = 0.02),且与脂肪肝和血清转氨酶升高密切相关,但后两个参数以及纤维化的组织学严重程度均不能很好地预测肝脏ATP的恢复情况。
这些数据表明,随着健康对照者体重增加,肝脏ATP耗竭后的恢复效率逐渐降低,而在肥胖相关的非酒精性脂肪性肝炎患者中则严重受损。